These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 10408755

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
    Dyck JR, Cheng JF, Stanley WC, Barr R, Chandler MP, Brown S, Wallace D, Arrhenius T, Harmon C, Yang G, Nadzan AM, Lopaschuk GD.
    Circ Res; 2004 May 14; 94(9):e78-84. PubMed ID: 15105298
    [Abstract] [Full Text] [Related]

  • 3. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5'-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase.
    Kudo N, Barr AJ, Barr RL, Desai S, Lopaschuk GD.
    J Biol Chem; 1995 Jul 21; 270(29):17513-20. PubMed ID: 7615556
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Alterations in fatty acid oxidation during reperfusion of the heart after myocardial ischemia.
    Lopaschuk GD.
    Am J Cardiol; 1997 Aug 04; 80(3A):11A-16A. PubMed ID: 9293951
    [Abstract] [Full Text] [Related]

  • 6. Targeting malonyl CoA inhibition of mitochondrial fatty acid uptake as an approach to treat cardiac ischemia/reperfusion.
    Ussher JR, Lopaschuk GD.
    Basic Res Cardiol; 2009 Mar 04; 104(2):203-10. PubMed ID: 19242641
    [Abstract] [Full Text] [Related]

  • 7. Metabolic response to an acute jump in cardiac workload: effects on malonyl-CoA, mechanical efficiency, and fatty acid oxidation.
    Zhou L, Huang H, Yuan CL, Keung W, Lopaschuk GD, Stanley WC.
    Am J Physiol Heart Circ Physiol; 2008 Feb 04; 294(2):H954-60. PubMed ID: 18083904
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions.
    Calvani M, Reda E, Arrigoni-Martelli E.
    Basic Res Cardiol; 2000 Apr 04; 95(2):75-83. PubMed ID: 10826498
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The malonyl CoA axis as a potential target for treating ischaemic heart disease.
    Ussher JR, Lopaschuk GD.
    Cardiovasc Res; 2008 Jul 15; 79(2):259-68. PubMed ID: 18499682
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase.
    Kantor PF, Lucien A, Kozak R, Lopaschuk GD.
    Circ Res; 2000 Mar 17; 86(5):580-8. PubMed ID: 10720420
    [Abstract] [Full Text] [Related]

  • 17. Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart.
    Jaswal JS, Keung W, Wang W, Ussher JR, Lopaschuk GD.
    Biochim Biophys Acta; 2011 Jul 17; 1813(7):1333-50. PubMed ID: 21256164
    [Abstract] [Full Text] [Related]

  • 18. Malonyl CoA control of fatty acid oxidation in the newborn heart in response to increased fatty acid supply.
    Onay-Besikci A, Sambandam N.
    Can J Physiol Pharmacol; 2006 Nov 17; 84(11):1215-22. PubMed ID: 17218986
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.